chloroquine and rifampin

chloroquine has been researched along with rifampin in 58 studies

Research

Studies (58)

TimeframeStudies, this research(%)All Research%
pre-19905 (8.62)18.7374
1990's2 (3.45)18.2507
2000's18 (31.03)29.6817
2010's28 (48.28)24.3611
2020's5 (8.62)2.80

Authors

AuthorsStudies
Clark, AM; Dunbar, DC; Muhammad, I; Takamatsu, S; Walker, LA1
Gochfeld, DJ; Hamann, MT1
Gerena, L; Milhous, WK; Opsenica, D; Pocsfalvi, G; Solaja, BA; Terzić, N; Tinant, B1
Al-Said, MS; Dunbar, DC; El Sayed, KA; Hamann, MT; Higa, T; Kelly, M; Orabi, KY1
Hamann, MT; Mesecar, AD; Rao, KV; Santarsiero, BD; Schinazi, RF; Tekwani, BL1
Hamann, MT; Kasanah, N; Rao, KV; Schinazi, RF; Tekwani, BL; Wahyuono, S1
König, GM; Papendorf, O; Wright, AD1
Alonso, D; Donia, MS; Franzblau, SG; Garcia-Palomero, E; Hamann, MT; Khan, SI; Martinez, A; Medina, M; Peng, J; Rao, KV; Tekwani, BL; Wahyuono, S; Willett, KL1
Karmodiya, K; Mishra, S; Ramya, TN; Surolia, A; Surolia, N1
Dahl, EL; Rosenthal, PJ1
Lombardo, F; Obach, RS; Waters, NJ1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Brun, R; Franzblau, SG; Huang, Q; Kozikowski, AP; Mao, J; Wan, B; Wang, Y1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choo, YM; Doerksen, RJ; Gertsch, J; Hamann, MT; Jacob, MR; Khan, SI; Kudrimoti, S; Madgula, V; Mayer, AM; Odde, S; Peng, J; Pennaka, HK; Prasanna, S; Rao, KV; Tekwani, BL; Tu, LC; Wang, B1
Chibale, K; Franzblau, SG; Guantai, EM; Gut, J; Hans, RH; Lategan, C; Rosenthal, PJ; Smith, PJ; Wan, B1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Glen, RC; Lowe, R; Mitchell, JB1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Barazarte, A; Camacho, J; Charris, J; Gamboa, N; Gilman, R; Rodrigues, J; Rojas, R; Vaisberg, A1
Chibale, K; Franzblau, SG; Gut, J; Hans, RH; Rosenthal, PJ; van Helden, PD; Wan, B; Wiid, IJ1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chaturvedi, V; Chauhan, K; Chauhan, PM; Puri, SK; Saxena, J; Saxena, JK; Sharma, M; Singh, SV; Srivastava, K; Trivedi, P1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Kalaria, PN; Raval, DK; Satasia, SP1
Karad, SC; Purohit, VB; Raval, DK1
Bharate, SB; Khan, IA; Khan, SI; Singh, S; Vishwakarma, RA; Yadav, RR1
Bourguet-Kondracki, ML; Chan, ST; Copp, BR; Dalton, JP; Page, MJ; Pearce, AN; Taylor, RB; Valentin, A; Wang, J; Wiles, S1
Franzblau, SG; Le Roch, KG; Nieves, K; Prudhomme, J; Rodríguez, AD1
Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Sankar, C; Umamatheswari, S1
Baell, J; Li, J; Nagalingam, G; Nguyen, N; Schneider, EK; Triccas, JA; Velkov, T; Wilson, DW1
Hoppe, H; Isaacs, M; Kaye, PT; Olawode, EO; Prinsloo, E; Seldon, R; Steenkamp, V; Tandlich, R; Warner, DF1
Baartzes, N; Chibale, K; Seldon, R; Smith, GS; Stringer, T; Taylor, D; Warner, DF; Wittlin, S1
Hoppe, HC; Isaacs, M; Kaye, PT; Krause, RWM; Manyeruke, MH; Seldon, R; Tshiwawa, T; Warner, DF1
Adhikari, N; Gaikwad, VR; Govindarajalu, G; Karale, UB; Krishna, EV; Krishna, VS; Misra, S; Rode, HB; Sijwali, PS; Sriram, D1
Boonlarppradab, C; Choowong, W; Kornsakulkarn, J; Saepua, S; Suriyachadkun, C; Thongpanchang, C1
Mason, CG1
Trautman, JR1
Artemenko, NK; Freidlin, IS; Lyzlova, SN; Nersesova, LS; Petrova, TA1
Benoliel, AM; Bongrand, P; Maurin, M; Raoult, D1
Youmans, AS; Youmans, GP1
Artemenko, NK; Freĭdlin, IS; Teĭber, EL; Voskresenskiĭ, AM1
Charoenlarp, P; Pukrittayakamee, S; Viravan, C; White, NJ; Wilson, RJ; Yeamput, C1
Bhat, M; Hickey, AJ1
Abdulah, MS; Hou, LJ; Nor, NM; Raju, SS; Ravichandran, M1
Chan, JC; Chau, CH; Chow, WS; Lam, KS; Lee, CH; Tso, AW; Yeung, CK; Yuen, MM1
Chen, Y; Huang, K; Jing, X; Lei, M; Liang, Y; Lin, D; Liu, J; Peng, S; Tao, E; Wu, X; Xiao, S; Yang, L; Zeng, Z; Zheng, D; Zhou, T1
Calender, A; Israel-Biet, D; Pacheco, Y; Valeyre, D1
Amro, L; Arjdal, B; Benali, SA; Bouaré, F; Etouche, FN; Ghannane, H; Hajhouji, F; Laghmari, M; Saidi, I; Tassi, N1

Reviews

3 review(s) available for chloroquine and rifampin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Ocular accumulation and toxicity of certain systemically administered drugs.
    Journal of toxicology and environmental health, 1977, Volume: 2, Issue:5

    Topics: Amitriptyline; Animals; Chloroquine; Cornea; Eye; Eye Diseases; Female; Haplorhini; Humans; Lens, Crystalline; Phenothiazines; Pregnancy; Retinal Diseases; Rifampin; Structure-Activity Relationship; Thioxanthenes; Time Factors

1977
Modeling Potential Autophagy Pathways in COVID-19 and Sarcoidosis.
    Trends in immunology, 2020, Volume: 41, Issue:10

    Topics: Angiotensin-Converting Enzyme Inhibitors; Autophagy; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Host-Pathogen Interactions; Humans; Isoniazid; Lung; Pandemics; Pneumonia, Viral; Pulmonary Edema; Rifampin; Sarcoidosis; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severity of Illness Index

2020

Other Studies

55 other study(ies) available for chloroquine and rifampin

ArticleYear
Antimalarial, cytotoxic, and antifungal alkaloids from Duguetia hadrantha.
    Journal of natural products, 2001, Volume: 64, Issue:5

    Topics: Alkaloids; Animals; Antifungal Agents; Antimalarials; Antineoplastic Agents, Phytogenic; Brazil; Cell Adhesion; Cell Aggregation; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Paraguay; Plant Extracts; Plants, Medicinal; Plasmodium falciparum; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured

2001
Isolation and biological evaluation of filiformin, plakortide F, and plakortone G from the Caribbean sponge Plakortis sp.
    Journal of natural products, 2001, Volume: 64, Issue:11

    Topics: Animals; Antimalarials; Bromobenzenes; Chromatography, High Pressure Liquid; Colonic Neoplasms; Dioxanes; Gas Chromatography-Mass Spectrometry; Hepatitis B; HIV; Humans; Jamaica; Lactones; Leukemia P388; Lung Neoplasms; Mice; Molecular Structure; Mycobacterium tuberculosis; Neoplasms, Unknown Primary; Nuclear Magnetic Resonance, Biomolecular; Plasmodium berghei; Plasmodium falciparum; Porifera; Spectrometry, Mass, Electrospray Ionization; Tumor Cells, Cultured

2001
Mixed steroidal 1,2,4,5-tetraoxanes: antimalarial and antimycobacterial activity.
    Journal of medicinal chemistry, 2002, Aug-01, Volume: 45, Issue:16

    Topics: Animals; Anti-Bacterial Agents; Antimalarials; Chlorocebus aethiops; Crystallography, X-Ray; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Spectrometry, Mass, Electrospray Ionization; Spiro Compounds; Steroids; Structure-Activity Relationship; Vero Cells

2002
Araguspongines K and L, new bioactive bis-1-oxaquinolizidine N-oxide alkaloids from Red Sea specimens of Xestospongia exigua.
    Journal of natural products, 2002, Volume: 65, Issue:12

    Topics: Alkaloids; Animals; Antimalarials; Antitubercular Agents; Indian Ocean; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Plasmodium falciparum; Porifera; Quinolizines; Rifampin; Stereoisomerism

2002
New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge.
    Journal of natural products, 2003, Volume: 66, Issue:6

    Topics: Alkaloids; Animals; Anti-HIV Agents; Antiprotozoal Agents; Carbazoles; Carbolines; Crystallography, X-Ray; Indoles; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Nucleosides; Porifera; Pyrroles; Stereoisomerism

2003
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases.
    Journal of natural products, 2004, Volume: 67, Issue:8

    Topics: Alkaloids; Animals; Anti-HIV Agents; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Carbolines; Indonesia; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Porifera

2004
Ambigol C and 2,4-dichlorobenzoic acid, natural products produced by the terrestrial cyanobacterium Fischerella ambigua.
    Journal of natural products, 2005, Volume: 68, Issue:3

    Topics: Animals; Antifungal Agents; Biphenyl Compounds; Carbazoles; Chlorobenzenes; Chlorobenzoates; Cyanobacteria; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Phenols; Switzerland; Trypanocidal Agents; Trypanosoma brucei rhodesiense

2005
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.
    Journal of natural products, 2006, Volume: 69, Issue:7

    Topics: Alzheimer Disease; Animals; Female; Glycogen Synthase Kinase 3; HIV-1; Humans; Indole Alkaloids; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oryzias; Plasmodium falciparum; Porifera; Structure-Activity Relationship

2006
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Acetone; Animals; Antimalarials; Azithromycin; Cerulenin; Chloramphenicol; Clindamycin; Erythrocytes; Fatty Acids; Gene Dosage; Humans; Organelles; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Tetracycline; Thioctic Acid; Triclosan

2007
Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Antimalarials; Drug Resistance; Flow Cytometry; Green Fluorescent Proteins; Plasmodium falciparum; Protein Synthesis Inhibitors; Topoisomerase II Inhibitors

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles.
    Journal of medicinal chemistry, 2009, Nov-12, Volume: 52, Issue:21

    Topics: Antimalarials; Antitubercular Agents; Benzothiazoles; Drug Design; Isoxazoles; Models, Molecular; Mycobacterium tuberculosis; Phenylacetates; Stereoisomerism; Structure-Activity Relationship; Trypanocidal Agents

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.
    Journal of medicinal chemistry, 2010, Jan-14, Volume: 53, Issue:1

    Topics: Animals; Anti-Infective Agents; Carbazoles; Cerebellar Diseases; Indole Alkaloids; Mice; Microbial Sensitivity Tests; Molecular Structure; Neurogenic Inflammation; Porifera; Stereoisomerism; Structure-Activity Relationship

2010
Synthesis, antimalarial and antitubercular activity of acetylenic chalcones.
    Bioorganic & medicinal chemistry letters, 2010, Feb-01, Volume: 20, Issue:3

    Topics: Alkynes; Antimalarials; Antitubercular Agents; Chalcones; Mycobacterium tuberculosis; Plasmodium falciparum

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents.
    Bioorganic & medicinal chemistry, 2011, Mar-15, Volume: 19, Issue:6

    Topics: Animals; Antimalarials; Antitubercular Agents; Benzimidazoles; Cell Line, Tumor; Drug Resistance, Multiple; Hemin; Hemoglobins; Humans; Hydrazines; Hydrolysis; Mice; Plasmodium

2011
Novel thiolactone-isatin hybrids as potential antimalarial and antitubercular agents.
    Bioorganic & medicinal chemistry letters, 2011, Apr-01, Volume: 21, Issue:7

    Topics: Animals; Antimalarials; Antitubercular Agents; Isatin; Lactones; Mycobacterium tuberculosis; Plasmodium falciparum; Structure-Activity Relationship

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Synthesis and biological evaluation of a new class of 4-aminoquinoline-rhodanine hybrid as potent anti-infective agents.
    European journal of medicinal chemistry, 2013, Volume: 62

    Topics: Aminoquinolines; Animals; Anti-Infective Agents; Chlorocebus aethiops; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Rhodanine; Structure-Activity Relationship; Vero Cells

2013
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
    European journal of medicinal chemistry, 2014, May-06, Volume: 78

    Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship

2014
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
    European journal of medicinal chemistry, 2014, Sep-12, Volume: 84

    Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship

2014
Synthesis, antimalarial and antitubercular activities of meridianin derivatives.
    European journal of medicinal chemistry, 2015, Jun-15, Volume: 98

    Topics: Animals; Antimalarials; Antitubercular Agents; Cell Line, Tumor; Humans; Indoles; Inhibitory Concentration 50; Plasmodium falciparum; Pyrimidines; Quantitative Structure-Activity Relationship; Sulfonamides

2015
Biologically Active Acetylenic Amino Alcohol and N-Hydroxylated 1,2,3,4-Tetrahydro-β-carboline Constituents of the New Zealand Ascidian Pseudodistoma opacum.
    Journal of natural products, 2016, Mar-25, Volume: 79, Issue:3

    Topics: Alkynes; Animals; Antimalarials; Carbolines; Chloroquine; Drug Resistance, Bacterial; Escherichia coli; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; New Zealand; Plasmodium falciparum; Staphylococcus aureus; Urochordata

2016
Natural product-based synthesis of novel anti-infective isothiocyanate- and isoselenocyanate-functionalized amphilectane diterpenes.
    Bioorganic & medicinal chemistry letters, 2016, Feb-01, Volume: 26, Issue:3

    Topics: Animals; Anti-Infective Agents; Biological Products; Cyanates; Diterpenes; Inhibitory Concentration 50; Isothiocyanates; Mycobacterium tuberculosis; Plasmodium falciparum; Porifera; Selenium Compounds

2016
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
    European journal of medicinal chemistry, 2016, Apr-13, Volume: 112

    Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis

2016
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.
    Bioorganic & medicinal chemistry letters, 2017, 02-01, Volume: 27, Issue:3

    Topics: Anti-Bacterial Agents; Antimalarials; Antitubercular Agents; Clostridium tetani; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Thiazines

2017
Broad activity of diphenyleneiodonium analogues against Mycobacterium tuberculosis, malaria parasites and bacterial pathogens.
    European journal of medicinal chemistry, 2018, Mar-25, Volume: 148

    Topics: Animals; Bacteria; Community-Acquired Infections; Cross Infection; Gram-Negative Bacteria; Gram-Positive Bacteria; Malaria; Mycobacterium tuberculosis; Onium Compounds; Structure-Activity Relationship

2018
Synthesis and biological evaluation of 2-chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones.
    Bioorganic & medicinal chemistry letters, 2019, 07-01, Volume: 29, Issue:13

    Topics: Humans; Molecular Structure; Naphthoquinones; Structure-Activity Relationship

2019
Bioisosteric ferrocenyl aminoquinoline-benzimidazole hybrids: Antimicrobial evaluation and mechanistic insights.
    European journal of medicinal chemistry, 2019, Oct-15, Volume: 180

    Topics: Animals; Anti-Bacterial Agents; Antimalarials; Benzimidazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Ferrous Compounds; Malaria; Mice; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship

2019
Synthesis and biological evaluation of bis-N
    Bioorganic & medicinal chemistry letters, 2020, 03-01, Volume: 30, Issue:5

    Topics: Antifungal Agents; Antitubercular Agents; Catalytic Domain; Coumarins; HeLa Cells; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Binding; Trypanocidal Agents; Trypanosoma brucei brucei

2020
Synthesis and efficacy of pyrvinium-inspired analogs against tuberculosis and malaria pathogens.
    Bioorganic & medicinal chemistry letters, 2020, 04-15, Volume: 30, Issue:8

    Topics: Antimalarials; Antitubercular Agents; Dose-Response Relationship, Drug; Malaria, Falciparum; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrvinium Compounds; Structure-Activity Relationship; Tuberculosis

2020
Antimicrobial and Cytotoxic Angucyclic Quinones from
    Journal of natural products, 2021, 11-26, Volume: 84, Issue:11

    Topics: Actinomadura; Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolones

2021
Treatment of Hansen's disease.
    Cutis, 1976, Volume: 18, Issue:1

    Topics: Chloroquine; Clofazimine; Dapsone; Drug Resistance, Microbial; Erythema Nodosum; Humans; Leprosy; Prednisone; Rifampin; Thalidomide

1976
[Changes in the functional activity of macrophages, their morphology and metabolism under the influence of several biologically active substances].
    Tsitologiia, 1975, Volume: 17, Issue:2

    Topics: Ascorbic Acid; Carbon Radioisotopes; Cathepsins; Chloramphenicol; Chloroquine; Creatine Kinase; Culture Techniques; Cycloheximide; Dactinomycin; Lipopolysaccharides; Lysine; Macrophages; Orotic Acid; Peritoneum; Phagocytosis; Protein Biosynthesis; Puromycin; Rifampin; RNA; Tetracycline; Uridine

1975
Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm.
    The Journal of infectious diseases, 1992, Volume: 166, Issue:5

    Topics: Amantadine; Ammonium Chloride; Animals; Anti-Bacterial Agents; Cell Line; Chloroquine; Coxiella burnetii; Doxycycline; Hydrogen-Ion Concentration; Lysosomes; Macrophages; Mice; Pefloxacin; Phagocytosis; Rifampin

1992
The effect of metabolic inhibitors and hydroxylamine on the immune response in mice to mycobacterial ribonucleic acid vaccines.
    Journal of immunology (Baltimore, Md. : 1950), 1974, Volume: 112, Issue:1

    Topics: Animals; Antibody Formation; Antimetabolites; Bacterial Vaccines; Chloramphenicol; Chloroquine; Cycloheximide; Dactinomycin; Ethidium; Flavins; Floxuridine; Hemagglutination Tests; Hydroxylamines; Male; Mice; Mycobacterium tuberculosis; Rifampin; RNA, Bacterial; Streptomycin; Vaccination

1974
[Changes in the immunologic response to bacteriophage T2 due to the transcription inhibitors actinomycin D, olivomycin, rifomycin and chloroquine].
    Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1972, Volume: 49, Issue:4

    Topics: Animals; Antibody Formation; Antigens, Viral; Chloroquine; Coliphages; Dactinomycin; Immunization; Mice; Oligomycins; Rifampin

1972
Antimalarial effects of rifampin in Plasmodium vivax malaria.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:3

    Topics: Adolescent; Adult; Animals; Chloroquine; Drug Therapy, Combination; Humans; Malaria, Vivax; Male; Middle Aged; Pilot Projects; Plasmodium vivax; Primaquine; Rifampin

1994
Effect of chloroquine on phagolysosomal fusion in cultured guinea pig alveolar macrophages: implications in drug delivery.
    AAPS pharmSci, 2000, Volume: 2, Issue:4

    Topics: Animals; Antibiotics, Antitubercular; Cells, Cultured; Chloroquine; Dextrans; Drug Synergism; Fluorescent Dyes; Guinea Pigs; Lysosomes; Macrophages, Alveolar; Microscopy, Fluorescence; Microspheres; Phagosomes; Rhodamines; Rifampin

2000
Rifampicin antagonizes the effect of choloroquine on chloroquine-resistant Plasmodium berghei in mice.
    Japanese journal of infectious diseases, 2004, Volume: 57, Issue:5

    Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Therapy, Combination; Malaria; Mice; Parasitemia; Plasmodium berghei; Rifampin

2004
A man with a blistering eruption and tuberculosis.
    BMJ (Clinical research ed.), 2012, Jan-06, Volume: 344

    Topics: Antimalarials; Antitubercular Agents; Chloroquine; Diagnosis, Differential; Drug Therapy, Combination; Feces; Hepatitis C; Humans; Iron Overload; Male; Middle Aged; Phlebotomy; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Rifampin; Risk Factors; Skin Diseases, Vesiculobullous; Tuberculosis, Pulmonary

2012
Rifampicin inhibits rotenone-induced microglial inflammation via enhancement of autophagy.
    Neurotoxicology, 2017, Volume: 63

    Topics: Analysis of Variance; Antirheumatic Agents; Autophagy; Cell Line, Tumor; Chloroquine; Coculture Techniques; Humans; Insecticides; Interleukin-1beta; Interleukin-6; Membrane Potential, Mitochondrial; Microglia; Microscopy, Electron, Transmission; Mitochondria; Neuroblastoma; Neuroprotective Agents; Reactive Oxygen Species; Rifampin; Rotenone

2017
Unusual association of COVID-19, pulmonary tuberculosis and human immunodeficiency virus, having progressed favorably under treatment with chloroquine and rifampin.
    The Pan African medical journal, 2020, Volume: 35, Issue:Suppl 2

    Topics: Adult; Antimalarials; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Diagnosis, Differential; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Rifampin; SARS-CoV-2; Tomography, X-Ray Computed; Tuberculosis, Pulmonary

2020